331252
National Data on “Unexpected” Newborn Complications
Method This analysis is based on the work of the California Maternal Quality Care Collaborative (CMQCC). It measures those newborns without preexisting complications that have an unexpectedmoderate or severe complication.
Results: The data covers the period 1/1/2012-12/31/2012 and 333,963 newborn/ inborn discharges from the National Perinatal Information Center Perinatal Center Data Base.
The overall rate of UNC was 3.6%, 38.9 % were coded with severe complications, 61.1 % with moderate complications.
For infants with moderate complications, 63.6% were admitted to a special care nursery, 78.1 % with severe complications were admitted.
Conclusion: The UNC rate provides perinatal leaders a relatively easy way to monitor unexpected adverse outcomes in a population that is generally not the focus of their attention.
Learning Areas:
Administration, management, leadershipOther professions or practice related to public health
Public health administration or related administration
Learning Objectives:
Define the Unexpected Newborn Complication (UNC) rate
Explain the rate algorithm as well as numerator and deominator inclusions and exclusions
Identify readily available data sources that can be used to calculate the UNC rate at the hospital, system and statewide level
Keyword(s): Birth Outcomes, Performance Measurement
Qualified on the content I am responsible for because: I am the President of the National Perinatal Information Center and have worked with administrative data sets for the past 30 years. The analysis presented was developed on our Perinatal Center Data Base and has been a metric that we include in all of our standard quarterly reports to our member hospitals. We are also using it as part of a panel of outcome metrics on a national quality improvement initiative with RTI.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.